Center-Authored Papers

Filters: Author is Rossouw, Jacques E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhao S, Chlebowski RT, Anderson GL, Kuller LH, Manson JE, Gass M, Patterson R, Rohan TE, Lane DS, Beresford SAA et al..  2014.  Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.. Breast cancer research : BCR. 16(2):R30. Abstract
S
Shufelt CL, Merz NBC, Prentice RL, Pettinger MB, Rossouw JE, Aroda VR, Kaunitz AM, Lakshminarayan K, Martin LW, Phillips LS et al..  2014.  Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.. Menopause (New York, N.Y.). 21(3):260-6. Abstract
Shimbo D, Wang L, Lamonte MJ, Allison M, Wellenius GA, Bavry AA, Martin LW, Aragaki A, Newman JD, Swica Y et al..  2014.  The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials.. Journal of hypertension. Abstract
R
Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC et al..  2014.  Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial: A Modeling Study.. Annals of internal medicine. 160(9):594-602. Abstract
Rossouw JE, Manson JE, Kaunitz AM, Anderson GL.  2013.  Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.. Obstetrics and gynecology. 121(1):172-6. Abstract
Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Rosendaal F, Rosing J, Wasserthal-Smoller S, Martin LW et al..  2012.  Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.. Stroke; a journal of cerebral circulation. 43(4):952-7. Abstract
Rossouw JE, Cushman M, Greenland P, Lloyd-Jones DM, Bray P, Kooperberg C, Pettinger M, Robinson J, Hendrix S, Hsia J.  2008.  Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.. Archives of internal medicine. 168(20):2245-53. Abstract
Rossouw JE, Prentice RL, Manson JE, Aragaki AK, Hsia J, Martin LW, Kuller L, Johnson KC, Eaton C, Jackson R et al..  2012.  Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.. Circulation. 126(13):1577-86. Abstract
P
Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J et al..  2009.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.. American journal of epidemiology. 170(1):12-23. Abstract
Prentice RL, Huang Y, Hinds DA, Peters U, Pettinger M, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B et al..  2009.  Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(11):3079-85. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH et al..  2008.  Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.. American journal of epidemiology. 167(12):1407-15. Abstract
Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM.  2013.  Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.. Genome medicine. 5(12):112. Abstract
Prentice RL, Aragaki AK, Horn LV, Thomson CA, Beresford SAA, Robinson J, Snetselaar L, Anderson GL, Manson JE, Allison MA et al..  2017.  Low-fat dietary pattern and cardiovascular disease: results from the Women's Health Initiative randomized controlled trial.. The American journal of clinical nutrition. Abstract
Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh MW, Wang P, Buson Busald T, Hsia J et al..  2010.  Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling.. Genome medicine. 2(7):48. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH, Lane DS et al..  2008.  Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.. American journal of epidemiology. 167(10):1207-16. Abstract
Prentice RL, Huang Y, Hinds DA, Peters U, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B, Ballinger DG.  2010.  Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(1):74-9. Abstract
Prentice RL, Manson JE, Anderson GL, LaCroix AZ, Shumaker SA, Chlebowski RT, Howard BV, Stefanick ML, Jackson RD, Wactawski-Wende J et al..  2013.  Women's Health Initiative View of Estrogen Avoidance and All-Cause Mortality.. American journal of public health. 103(12):e2.
Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM et al..  2009.  Postmenopausal estrogen and progestin effects on the serum proteome.. Genome medicine. 1(12):121. Abstract
M
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ et al..  2013.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.. JAMA : the journal of the American Medical Association. 310(13):1353-68. Abstract
L
Liu C, Kraja AT, Smith JA, Brody JA, Franceschini N, Bis JC, Rice K, Morrison AC, Lu Y, Weiss S et al..  2016.  Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.. Nature genetics. 48(10):1162-1170. Abstract
Liu Q, Rossouw JE, Roberts MB, Liu S, Johnson KC, Shikany JM, Manson JE, Tinker LF, Eaton CB.  2017.  Theoretical effects of substituting butter with margarine on risk of cardiovascular disease.. Epidemiology (Cambridge, Mass.). 28(1):145-156. Abstract
Li M, Li Y, Weeks O, Mijatovic V, Teumer A, Huffman JE, Tromp G, Fuchsberger C, Gorski M, Lyytikäinen L-P et al..  2016.  SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function.. Journal of the American Society of Nephrology : JASN. Abstract
J
Johnson KC, Aragaki AK, Jackson R, Reiner A, Sandset PM, Rosing J, Dahm AEA, Rosendaal F, Manson JE, Martin LW et al..  2015.  Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.. Arteriosclerosis, thrombosis, and vascular biology. Abstract
H
Huang Y, Ballinger DG, Stokowski R, Beilharz E, Robinson JG, Liu S, Robinson R, Henderson VW, Rossouw JE, Prentice RL.  2012.  Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk.. Genome medicine. 4(7):57. Abstract
Huang Y, Ballinger DG, Dai JY, Peters U, Hinds DA, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, McTiernan A et al..  2011.  Genetic variants in the MRPS30 region and postmenopausal breast cancer risk.. Genome medicine. 3(6):42. Abstract